Detorsion is not innocent: pirfenidone prevents contralateral ovarian damage following ovarian torsion
Open Access
- 13 March 2026
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (8) , 12507-12519
Abstract
Ovarian torsion is a gynecological emergency caused by rotation of the vascular pedicle, leading to ischemia, necrosis, and potential fertility loss. Management remains controversial, particularly regarding oophorectomy versus ovarian preservation. Detorsed ovaries continue cytokine secretion, impairing contralateral ovarian function, and no protective therapy currently exists. This study aimed to compare oophorectomy and detorsion strategies and to determine whether post-detorsion long-term pirfenidone therapy preserves ovarian function, thereby providing experimental resolution to the clinically pivotal “save or sacrifice” dilemma. Forty female rats were divided into five groups: Healthy, IR, IR + OVX, IR + Pirfenidone 50 mg/kg, and IR + Pirfenidone 100 mg/kg. Ischemia was induced in the left ovary of IR groups; in IR + OVX, the ovary was excised at 3 h, while in other groups, ovaries were reperfused. Treatments continued for 30 days. Ovarian tissues and blood were analyzed histopathologically, biochemically, and molecularly. Ovarian ischemia–reperfusion induced a persistent inflammatory and profibrotic response not only in the ischemic ovary but also in the contralateral ovary, leading to reduced estrogen levels and marked histopathological damage. Importantly, detorsion alone did not prevent contralateral injury, whereas oophorectomy attenuated molecular alterations. Post-detorsion pirfenidone therapy dose-dependently restored estrogen production, suppressed inflammasome activation (IL-1β, NLRP3, caspase-1) and fibrotic signaling (SMAD2, SMAD3, TGF-β1), and preserved normal follicular architecture in both ovaries. These findings demonstrate that the detorsed ovary remains a biologically active source of injury and identify pirfenidone as a potential adjunct therapy capable of protecting ovarian function after torsion.Keywords
Funding Information
- Atatürk University
This publication has 60 references indexed in Scilit:
- Anti-inflammatory effect of pirfenidone compared to dexamethasone in ulcerative colitis model induced by acetic acid in rats: involvement of miR-146a and TLR4/NF-κB signalingNaunyn-Schmiedeberg's Archives of Pharmacology, 2025
- Targeting Aquaporin-5 by Phosphodiesterase 4 Inhibition Offers New Therapeutic Opportunities for Ovarian Ischemia Reperfusion Injury in RatsReproductive Sciences, 2024
- High risk and low prevalence diseases: Ovarian torsionThe American Journal of Emergency Medicine, 2022
- Correction to: Ovarian torsion: developing a machine-learned algorithm for diagnosisPediatric Radiology, 2020
- Imaging in gynecological disease (20): clinical and ultrasound characteristics of adnexal torsionUltrasound in Obstetrics & Gynecology, 2020
- Increase of SOX9 promotes hepatic ischemia/reperfusion (IR) injury by activating TGF-β1Biochemical and Biophysical Research Communications, 2018
- GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trialJournal of Assisted Reproduction and Genetics, 2017
- Studying the Functions of TGF-β Signaling in the Ovary2016
- Inhibition of CDK2 promotes inducible regulatory T-cell differentiation through TGFβ-Smad3 signaling pathwayCellular Immunology, 2014
- Ultrastructural and hormonal changes in the contralateral adrenal gland in unilateral adrenal gland ischemia: An experimental study in ratsSurgery Today, 1998